GHK-Cu 50mg

GHK-Cu 50 mg (copper tripeptide-1) is an investigational peptide that researchers study in tissue repair and wound-healing research. The ClinicalTrials.gov record NCT07437586 describes a Phase 2, randomized, double-blind, vehicle-controlled study. Investigators evaluate topical GHK-Cu gel (0.1% w/w) in standardized acute skin wounds in healthy adults.

We position this 50 mg presentation for research and clinical-trial supply. It supports sponsors, CROs, hospitals, and procurement teams that require defined peptide material and documentation.

We support your program with:

• Custom peptide synthesis and material definition
• Identity, purity, and impurity characterization
• Analytical verification and batch consistency
• Stability and storage planning
• Documentation: CoA, batch records, analytical summaries
• Controlled handling and study-aligned supply